Cetera Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-4,778
Closed -$351K 2
2017
Q2
$351K Sell
4,778
-1,117
-19% -$75.1K 0.44% 76
2017
Q1
$384K Sell
5,895
-3,781
-39% -$238K 0.44% 84
2016
Q4
$606K Sell
9,676
-1,757
-15% -$107K 0.45% 84
2016
Q3
$721K Sell
11,433
-1,484
-11% -$96.1K 0.46% 75
2016
Q2
$800K Sell
12,917
-1,805
-12% -$110K 0.47% 77
2016
Q1
$848K Sell
14,722
-755
-5% -$42.1K 0.44% 81
2015
Q4
$913K Buy
+15,477
New +$891K 0.37% 104

Other funds holding ABBV

Cetera Investment Management's ABBV Position: Q3 2017 in Review

Cetera Investment Management sold out of AbbVie (ABBV) in Q3 2017, closing a stake of 4,778 shares — an estimated $351K sold.

Cetera Investment Management first reported a position in ABBV in Q4 2015 and held it in 7 quarters. The position peaked at $913K in Q4 2015. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

  • Cetera Investment Management reported no remaining AbbVie position as of Q3 2017 after selling out during the quarter.
  • Cetera Investment Management sold 4,778 AbbVie shares in Q3 2017, an estimated $351K.
  • Cetera Investment Management first reported a position in AbbVie in Q4 2015 and held it in 7 quarters.
  • Cetera Investment Management's AbbVie position peaked at $913K in Q4 2015.
  • 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Cetera Investment Management's 13F filing for Q3 2017.